ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 17, 9 Issues, 2017


Download PDF Flyer




Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446

Upcoming Articles (E-Pub Abstracts ahead of Print)

HIF1A is overexpressed in medulloblastoma and its inhibition reduces proliferation and increases EPAS1 and ATG16L1 methylation


Gustavo Alencastro Veiga Cruzeiro, Maristella Bergamo dos Reis, Vanessa Silva Silveira, Régia Caroline Peixoto Lira, Carlos Gilberto Carlotti Jr, Luciano Neder, Ricardo Santos Oliveira, José Andres Yunes, Silvia Regina Brandalise, Simone Aguiar, Agda Karina Eterovic, Luiz Gonzaga Tone, Carlos Alberto Scrideli and Elvis Terci Valera.


View Abstract


Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects


Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis.


View Abstract


The development of oncoltyic adenovirus therapy in the past and future - For the case of pancreatic cancer


Mizuho Sato-Dahlman and Masato Yamamoto.


View Abstract


Emergence of Ad-mediated combination therapy against cancer: What to expect?


JinWoo Hong and Chae-Ok Yun.


View Abstract


The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality


Sebastiano Bordonaro, Massimiliano Berretta, Antonino Carmelo Tralongo, Silvia Clementi, Brigida Stanzione and Paolo Tralongo.


View Abstract


The Role of Target Therapy in the Treatment of Gastrointestinal Non Colorectal Cancers: Clinical Impact and Cost Consideration.


Massimiliano Berretta, Raffaele Di Francia, Chiara De Diviitis, Guglielmo Nasti, Vincenzo Canzonieri, Michele Caraglia, Gaetano Facchini and Umberto Tirelli.


View Abstract


Lung cancer stem cells: An epigenetic perspective


Samriddhi Shukla, Sajid Khan, Sonam Sinha and Syed Musthapa Meeran.


View Abstract


Mechanisms for inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase (hTERT) down-regulation


Samantha L. Martin, Rishabh Kala and Trygve O Tollefsbol.


View Abstract


Multimodal HDAC inhibitors with improved anticancer activity


Rainer Schobert and Bernhard Biersack.


View Abstract


Transforming Cancer Epigenetics Using Nutritive Approaches and Non-coding RNAs


Centdrika R. Dates and Trygve O Tollefsbol.


View Abstract


Epigenetics in clinical management of children and adolescents with brain tumors


Andres Morales La Madrid and Mark W Kieran.


View Abstract


Outlook on epigenetic therapeutic approaches for treatment of gastric cancer.


Petra Hudler.


View Abstract


Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer


Karen O’Leary, Alice Shia and Peter Schmid.


View Abstract


Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects


Avineesh Singh, Preeti Patel, Vijay Patel, Deepak K Jain, Ravichandran Veerasamy, Prabodh Chandere Sharma and Harish Rajak.


View Abstract


Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017Orphan Drugs and Rare Diseases Europe 2017

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science